Exchange: NASDAQ·Updated 02:11 PM EDT
XERS logo

XERSXeris Biopharma Holdings Inc

$8.34
$0.07
(0.83%)
Today
EarningsAug 6
Mkt Cap$1.45B
Vol565,512.00

About

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
435

Frequently Asked Questions

What is Market Cap of Xeris Biopharma Holdings Inc?
What is the 52-week high for Xeris Biopharma Holdings Inc?
What is the 52-week low for Xeris Biopharma Holdings Inc?
What is Xeris Biopharma Holdings Inc stock price today?
What was Xeris Biopharma Holdings Inc stock price yesterday?
What is the PE ratio of Xeris Biopharma Holdings Inc?
What is the Price-to-Book ratio of Xeris Biopharma Holdings Inc?
What is the 50-day moving average of Xeris Biopharma Holdings Inc?
How many employees does Xeris Biopharma Holdings Inc have?

Advertisement|Remove ads.